ArticlePharmaceutical research2015

The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.

Shiguo Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.